(Reuters) - A key U.S. government trial of Gilead Sciences Inc’s experimental coronavirus treatment may yield results as early as mid-May, according to...
Hello and welcome back to Equity, TechCrunch’s venture capital-focused podcast, where we unpack the numbers behind the headlines.
This week we had a choice...